GGrantIndex
Sort

11,323 grants matching glioblastoma

Regulation of Wnt Signaling by PAP2b During Angiogenesis

$171,347
Kishore K Wary · University Of Illinois At Chicago · R01 · FY2009 · HL

Gene-engineered adoptive T cell immunotherapy of GBM

$171,253
Laura A Johnson · University Of Pennsylvania · DP2 · FY2015 · CA

An Investigation of the Cell of Origin in Gliomagenesis

$171,229
Dana-Farber Cancer Institute · K08 · FY2002 · NS

An Investigation of the Cell of Origin in Gliomagenesis

$171,229
Dana-Farber Cancer Institute · K08 · FY2003 · NS

An Investigation of the Cell of Origin in Gliomagenesis

$171,229
Dana-Farber Cancer Institute · K08 · FY2004 · NS

An Investigation of the Cell of Origin in Gliomagenesis

$171,229
Dana-Farber Cancer Institute · K08 · FY2005 · NS

A new class of CSF-1R radioligands for monitoring glioblastoma progression and therapy

$171,060
Frederick T Chin · Stanford University · R21 · FY2018 · CA

Dual imaging and therapeutic targeting agents for glioblastoma

$171,000
Ruiwu Liu · University Of California At Davis · R21 · FY2008 · CA

Elimination of Carcinogen-Induced Tumor Stem Cells by ATF5 Loss of Function.

$171,000
James M Angelastro · University Of California At Davis · R21 · FY2008 · CA

Regulation of glioblastoma cells by GABAergic neurons in human organoid-tumor chimeras

$170,988
Oleksandr Shcheglovitov · University Of Utah · R21 · FY2024 · CA

Characterization of GEFT AS a Novel Glioblastoma Oncogene

$170,861
Milan Girish Chheda · Sloan-Kettering Inst Can Research · K08 · FY2011 · NS

Characterization of GEFT AS a Novel Glioblastoma Oncogene

$170,861
Milan Girish Chheda · Sloan-Kettering Inst Can Research · K08 · FY2012 · NS

Core C - Clinical Trials

$170,818
John M Buatti · University Of Iowa · P01 · FY2019 · CA

Understanding Sex Disparities in Gliomas Through Sex Differences in Mitochondrial Activity

$170,783
Joseph Edward Ippolito · Washington University · R21 · FY2019 · CA

Plasmacytoid Dendritic Cells in Malignant Glioma

$170,748
Mahua Dey · University Of Wisconsin-Madison · K08 · FY2020 · NS

(PQ5) Assessing the contribution of mitochondrial heterogeneity to gliomagenesis using single cell approaches

$170,738
Vivian Gama · Vanderbilt University · R21 · FY2020 · CA

CLINICAL TRIALS IN USE OF PHOTODYNAMIC THERAPY FOR SUPRAFRONTAL BRAIN TUMORS

$170,721
Healthone Alliance · P01 · FY2000 · CA

MECHANISMS OF PDT INDUCED AND INHERENT RESISTANCE

$170,721
Healthone Alliance · P01 · FY2000 · CA

Mapping Intercellular Protein Trafficking in Glioblastoma with Esterase-Activated Proximity Labeling

$170,655
Shizhong Dai · Stanford University · K99 · FY2025 · CA

In situ assay imaging nuclear RNA exosome activity for cancer studies

$170,520
Vladimir V Didenko · Baylor College Of Medicine · R21 · FY2022 · CA

In situ assay imaging nuclear RNA exosome activity for cancer studies

$170,520
Vladimir V Didenko · Baylor College Of Medicine · R21 · FY2023 · CA

Discovery of PPI inhibitors for the FAK FAT domain

$170,433
Timothy A Marlowe · University Of Arizona · R21 · FY2024 · CA

Administrative Core

$170,427
John H Sampson · Duke University · P01 · FY2022 · CA

Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4

$170,339
Tracy T Batchelor · Brigham And Women'S Hospital · U19 · FY2022 · CA

UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ

$170,248
Timothy Cloughesy · University Of California Los Angeles · M01 · FY2009 · RR